Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001188217 | SCV001355233 | uncertain significance | Cardiomyopathy | 2019-01-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002480623 | SCV002793758 | uncertain significance | Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163462 | SCV003855326 | uncertain significance | Cardiovascular phenotype | 2022-12-05 | criteria provided, single submitter | clinical testing | The c.3337-2_3337delAGGinsCAGA variant results from a deletion of 3 nucleotides and insertion of 4 nucleotides between positions c.3337-2 and c.3337. This variant impacts the first base pair of coding exon 25, but does not impact the canonical splice acceptor site before coding exon 25 of the MYH7 gene. This nucleotide region is highly conserved in available vertebrate species. Using the BDGP splice site prediction tool, this alteration does not have any significant effect on the native acceptor splice site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |